CID 131769999

4-trans-hydroxyglipizide

Structural Information

Molecular Formula
C21H27N5O5S
SMILES
CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)O
InChI
InChI=1S/C21H27N5O5S/c1-14-12-24-19(13-23-14)20(28)22-11-10-15-2-8-18(9-3-15)32(30,31)26-21(29)25-16-4-6-17(27)7-5-16/h2-3,8-9,12-13,16-17,27H,4-7,10-11H2,1H3,(H,22,28)(H2,25,26,29)
InChIKey
WPQWQJBFAJEUHS-UHFFFAOYSA-N
Compound name
N-[2-[4-[(4-hydroxycyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-methylpyrazine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

461.17328 Da
Monoisotopic Mass

0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 462.18056 202.1
[M+Na]+ 484.16250 208.9
[M+NH4]+ 479.20710 204.7
[M+K]+ 500.13644 204.2
[M-H]- 460.16600 204.5
[M+Na-2H]- 482.14795 207.4
[M]+ 461.17273 203.5
[M]- 461.17383 203.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe